Skip to main content
Erschienen in: Strahlentherapie und Onkologie 3/2012

01.11.2012 | Originalien

Die technischen und methodischen Entwicklungen der Radioonkologie aus ärztlicher Sicht

verfasst von: Prof. Dr. N. Willich

Erschienen in: Strahlentherapie und Onkologie | Sonderheft 3/2012

Einloggen, um Zugang zu erhalten

Zusammenfassung

Technische und methodische Entwicklungen der letzten 40 Jahre haben das Gesicht der Radioonkologie wesentlich verändert. Moderne bildgebende Verfahren, wie Computertomographie (CT), Magnetresonanztomographie (MRI), Positronenemissionstomographie (PET) und Ultraschall haben nicht nur die Erkennbarkeit von Tumoren verbessert, sondern fanden auch Eingang in die computerisierte Bestrahlungsplanung. Die Megavoltbestrahlung mit Photonen und Elektronen aus Beschleunigern mit großen und kleinen Bestrahlungsfeldern, mit Fluenz(Intensitäts)modulation (IMRT), bildgeführter Strahlentherapie (IGRT), stereotaktischer Radiotherapie und Radiochirurgie, intraoperativer Strahlentherapie (IORT) sowie die moderne Brachytherapie im ferngesteuerten Afterloading-Verfahren haben zunehmend Methoden für immer präzisere Strahlenapplikationen bis hin zur Hochpräzisionsbestrahlung zur Verfügung gestellt. Hadronentherapie hat dabei ein weiteres Entwicklungspotential. Die Radioonkologie ist mit diesen Methoden an der Hälfte aller Kurationen beteiligt und hat ein hohes Potenzial in der palliativen Therapie. Die moderne Strahlentherapie ist heute interdisziplinär und berücksichtigt zunehmend Interaktionen mit neuen Medikamenten sowie differenzierten operativen Methoden. Daher besteht ein umfassender Evaluationsbedarf der neuen Methoden wie auch ein hoher Bedarf an translationaler Forschung auf den Gebieten der Tumor- und Normalgewebsbiologie sowie der medizinischen Physik und Technik.
Literatur
1.
Zurück zum Zitat Kaplan HS (1972) Hodgkin’s disease, Cambridge, Mass. Harvard University Press. Zitiert nach: Musshoff K, Slanina J (1976) Maligne Systemerkrankungen. In: Scherer E (Hrsg) Strahlentherapie, 1. Aufl. Springer, S 733 Kaplan HS (1972) Hodgkin’s disease, Cambridge, Mass. Harvard University Press. Zitiert nach: Musshoff K, Slanina J (1976) Maligne Systemerkrankungen. In: Scherer E (Hrsg) Strahlentherapie, 1. Aufl. Springer, S 733
2.
Zurück zum Zitat Suit H (1983) Radiation biology: the conceptual and practical impact on radiation therapy. Radiat Res 10–40. Zitiert nach: Halperin EC, Perez CA, Brady LW (2008) The discipline of radiation oncology. In: Perez and Brady’s principles and practice of radiation. Oncology, 5. Aufl. S 2–75) Suit H (1983) Radiation biology: the conceptual and practical impact on radiation therapy. Radiat Res 10–40. Zitiert nach: Halperin EC, Perez CA, Brady LW (2008) The discipline of radiation oncology. In: Perez and Brady’s principles and practice of radiation. Oncology, 5. Aufl. S 2–75)
3.
Zurück zum Zitat Eich HT, Müller RP, Engenhart-Cabillic R et al (2008) Involved-node radiotherapy in early-stage Hodgkin’s lymphoma. Definition and guidelines of the German Hodgkin Study Group (GHSG). Strahlenther Onkol 184(8):406–410PubMedCrossRef Eich HT, Müller RP, Engenhart-Cabillic R et al (2008) Involved-node radiotherapy in early-stage Hodgkin’s lymphoma. Definition and guidelines of the German Hodgkin Study Group (GHSG). Strahlenther Onkol 184(8):406–410PubMedCrossRef
4.
Zurück zum Zitat Salazar OM, DaMotta NW, Bridgman SM et al (1996) Fractionated half-body irradiation for pain palliation in widely metastatic cancers: comparison with single dose. Int J Radiat Oncol Biol Phys 36(1):49–60PubMedCrossRef Salazar OM, DaMotta NW, Bridgman SM et al (1996) Fractionated half-body irradiation for pain palliation in widely metastatic cancers: comparison with single dose. Int J Radiat Oncol Biol Phys 36(1):49–60PubMedCrossRef
5.
Zurück zum Zitat Salazar OM, Rubin P, Hendrickson FR et al (1986) Single-dose half-body irradiation for palliation of multiple boueg metastases from solid tumors. Final Radiation Therapy Oncology Group report. Cancer 58(1):29–36PubMedCrossRef Salazar OM, Rubin P, Hendrickson FR et al (1986) Single-dose half-body irradiation for palliation of multiple boueg metastases from solid tumors. Final Radiation Therapy Oncology Group report. Cancer 58(1):29–36PubMedCrossRef
6.
Zurück zum Zitat Gunderson LL, Sosin H (1974) Areas of failure found at reoperation (second or symptomatic look), following curative surgery for adenocarcinoma of rectum. Cancer 34(4):1278–1292PubMedCrossRef Gunderson LL, Sosin H (1974) Areas of failure found at reoperation (second or symptomatic look), following curative surgery for adenocarcinoma of rectum. Cancer 34(4):1278–1292PubMedCrossRef
7.
Zurück zum Zitat Jensen JM, Brix F, Hancken C et al (1988) Field-integrated dosage modification (FIDM). 2. The physical principles of the procedure. Strahlenther Onkol 164(2):85–90PubMed Jensen JM, Brix F, Hancken C et al (1988) Field-integrated dosage modification (FIDM). 2. The physical principles of the procedure. Strahlenther Onkol 164(2):85–90PubMed
8.
Zurück zum Zitat Brix F, Christiansen R, Hancken C et al (1988) The field integrated dose modification (FIDM): three typical clinical applications of a new irradiation technique. Radiother Oncol 12(3):199–207PubMedCrossRef Brix F, Christiansen R, Hancken C et al (1988) The field integrated dose modification (FIDM): three typical clinical applications of a new irradiation technique. Radiother Oncol 12(3):199–207PubMedCrossRef
9.
Zurück zum Zitat Nilsson S, Norlen BJ, Widmark A (2004) A systematic overview of radiation therapy effects in prostate cancer. Acta Oncol 43:316–381PubMedCrossRef Nilsson S, Norlen BJ, Widmark A (2004) A systematic overview of radiation therapy effects in prostate cancer. Acta Oncol 43:316–381PubMedCrossRef
10.
Zurück zum Zitat Zelefsky MJ, Fuks Z, Happersett L et al (2000) Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol 55:241–249PubMedCrossRef Zelefsky MJ, Fuks Z, Happersett L et al (2000) Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol 55:241–249PubMedCrossRef
11.
Zurück zum Zitat Zelefsky MJ, Fuks Z, Hunt M et al (2002) High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 53:1111–1116PubMedCrossRef Zelefsky MJ, Fuks Z, Hunt M et al (2002) High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 53:1111–1116PubMedCrossRef
12.
Zurück zum Zitat Kuppersmith RB, Greco SC, Teh BS et al (1999) Intensity-modulated radiotherapy: first results with this new technology on neoplasms of the head and neck. Ear Nose Throat J 78:238–241PubMed Kuppersmith RB, Greco SC, Teh BS et al (1999) Intensity-modulated radiotherapy: first results with this new technology on neoplasms of the head and neck. Ear Nose Throat J 78:238–241PubMed
13.
Zurück zum Zitat Butler EH, The BS, Grant WH et al (1999) SMART (Simultaneous Modulated Accelerated Radiation Therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 45:21–32PubMedCrossRef Butler EH, The BS, Grant WH et al (1999) SMART (Simultaneous Modulated Accelerated Radiation Therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 45:21–32PubMedCrossRef
14.
Zurück zum Zitat Chao KS, Deasy JO, Markman J et al (2001) A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys 49:907–916PubMedCrossRef Chao KS, Deasy JO, Markman J et al (2001) A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys 49:907–916PubMedCrossRef
15.
Zurück zum Zitat Chao KS, Majhail N, Huang CJ et al (2001) Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques. Radiother Oncol 61:275–280PubMedCrossRef Chao KS, Majhail N, Huang CJ et al (2001) Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques. Radiother Oncol 61:275–280PubMedCrossRef
16.
Zurück zum Zitat Cheng JC, Chao KS, Low DA et al (2001) Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma. Int J Cancer 96:126–131PubMedCrossRef Cheng JC, Chao KS, Low DA et al (2001) Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma. Int J Cancer 96:126–131PubMedCrossRef
17.
Zurück zum Zitat Lin A, Kim HM, Terrell JE et al (2003) Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study. Int J Radiat Oncol Biol Phys 57:61–70PubMedCrossRef Lin A, Kim HM, Terrell JE et al (2003) Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study. Int J Radiat Oncol Biol Phys 57:61–70PubMedCrossRef
18.
Zurück zum Zitat Lee N, Xia P, Quivey JM et al (2002) Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 53:12–22PubMedCrossRef Lee N, Xia P, Quivey JM et al (2002) Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 53:12–22PubMedCrossRef
19.
Zurück zum Zitat Wolden SL, Chen WC, Pfister DG et al (2005) Intensity-modulated radiationtherapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan kettering experience. Int J Radiat Oncol Biol Phys 64(1):57–62PubMedCrossRef Wolden SL, Chen WC, Pfister DG et al (2005) Intensity-modulated radiationtherapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan kettering experience. Int J Radiat Oncol Biol Phys 64(1):57–62PubMedCrossRef
20.
Zurück zum Zitat Yao M, Dornfeld KJ, Buatti JM et al (2005) Intensity-modulated radiationtreatment for head-and-neck squamous cell carcinoma-the University of Iowa experience. Int J Radiat Oncol Biol Phys 63:410–421PubMedCrossRef Yao M, Dornfeld KJ, Buatti JM et al (2005) Intensity-modulated radiationtreatment for head-and-neck squamous cell carcinoma-the University of Iowa experience. Int J Radiat Oncol Biol Phys 63:410–421PubMedCrossRef
21.
Zurück zum Zitat Chao KS, Wippold FJ, Ozyigit G et al (2005) Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. Int J Radiat Oncol Biol Phys 53:1117–1184 Chao KS, Wippold FJ, Ozyigit G et al (2005) Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. Int J Radiat Oncol Biol Phys 53:1117–1184
22.
Zurück zum Zitat Dawson LA, Anzai Y, Marsh L et al (2000) Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 46:1117–1126PubMedCrossRef Dawson LA, Anzai Y, Marsh L et al (2000) Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 46:1117–1126PubMedCrossRef
23.
Zurück zum Zitat Münter MW, Thilmann C, Hof H et al (2003) Stereotactic intensity modulated radiation therapy and inverse treatment planning for tumors of the head and neck region: clinical implementation of the step and shoot approach and first clinical results. Radiother Oncol 66:313–321PubMedCrossRef Münter MW, Thilmann C, Hof H et al (2003) Stereotactic intensity modulated radiation therapy and inverse treatment planning for tumors of the head and neck region: clinical implementation of the step and shoot approach and first clinical results. Radiother Oncol 66:313–321PubMedCrossRef
24.
Zurück zum Zitat Nestle U, Kremp S, Grosu AL (2006) Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives. Radiother Oncol 81(2):209–225PubMedCrossRef Nestle U, Kremp S, Grosu AL (2006) Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives. Radiother Oncol 81(2):209–225PubMedCrossRef
25.
Zurück zum Zitat Grosu AL, Piert M, Weber WA et al (2005) Positron emission tomography for radiation treatment planning. Strahlenther Onkol 181(8):483–499PubMedCrossRef Grosu AL, Piert M, Weber WA et al (2005) Positron emission tomography for radiation treatment planning. Strahlenther Onkol 181(8):483–499PubMedCrossRef
26.
Zurück zum Zitat Sura S, Greco C, Gelblum D et al (2008) (18)F-fluorodeoxyglucose positron emission tomography-based assessment of local failure patterns in non-small-cell lung cancer treated with definitive radiotherapy. Int J Radiat Oncol Biol Phys 70(5):1397–1402PubMedCrossRef Sura S, Greco C, Gelblum D et al (2008) (18)F-fluorodeoxyglucose positron emission tomography-based assessment of local failure patterns in non-small-cell lung cancer treated with definitive radiotherapy. Int J Radiat Oncol Biol Phys 70(5):1397–1402PubMedCrossRef
27.
Zurück zum Zitat Reske SN, Kotzerke J (2001) FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, „Onko-PET III“, 21 July and 19 September 2000. Eur J Nucl Med 28(11):1707–1723PubMedCrossRef Reske SN, Kotzerke J (2001) FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, „Onko-PET III“, 21 July and 19 September 2000. Eur J Nucl Med 28(11):1707–1723PubMedCrossRef
28.
29.
Zurück zum Zitat Grosu AL, Weber WA, Franz M et al (2005) Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. Int J Radiat Oncol Biol Phys 63(2):511–519PubMedCrossRef Grosu AL, Weber WA, Franz M et al (2005) Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. Int J Radiat Oncol Biol Phys 63(2):511–519PubMedCrossRef
30.
Zurück zum Zitat Astner ST, Dobrei-Ciuchendea M, Essler M et al (2008) Effect of 11C-methionine-positron emission tomography on gross tumor volume delineation in stereotactic radiotherapy of skull base meningiomas. Int J Radiat Oncol Biol Phys 72(4):1161–1167PubMedCrossRef Astner ST, Dobrei-Ciuchendea M, Essler M et al (2008) Effect of 11C-methionine-positron emission tomography on gross tumor volume delineation in stereotactic radiotherapy of skull base meningiomas. Int J Radiat Oncol Biol Phys 72(4):1161–1167PubMedCrossRef
31.
Zurück zum Zitat Andrews DW, Scott CB, Sperduto PW et al (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363(9422):1665–1672PubMedCrossRef Andrews DW, Scott CB, Sperduto PW et al (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363(9422):1665–1672PubMedCrossRef
32.
Zurück zum Zitat Mehta MP, Tsao MN, Whelan TJ et al (2005) The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 63(1):37–46PubMedCrossRef Mehta MP, Tsao MN, Whelan TJ et al (2005) The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 63(1):37–46PubMedCrossRef
33.
Zurück zum Zitat Pollock BE, Stafford SL (2005) Results of stereotactic radiosurgery for patients with imaging defined cavernous sinus meningiomas. Int J Radiat Oncol Biol Phys 62(5):1427–1431PubMedCrossRef Pollock BE, Stafford SL (2005) Results of stereotactic radiosurgery for patients with imaging defined cavernous sinus meningiomas. Int J Radiat Oncol Biol Phys 62(5):1427–1431PubMedCrossRef
34.
Zurück zum Zitat Kondziolka D, Flickinger JC, Dade Lunsford L (2011) Clinical research in stereotactic radiosurgery: lessons learned from over 10,000 cases. Neurol Res 33(8):792–802PubMedCrossRef Kondziolka D, Flickinger JC, Dade Lunsford L (2011) Clinical research in stereotactic radiosurgery: lessons learned from over 10,000 cases. Neurol Res 33(8):792–802PubMedCrossRef
35.
Zurück zum Zitat Sheehan JP, Niranjan A, Sheehan JM et al (2005) Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium. J Neurosurg 102(4):678–691PubMedCrossRef Sheehan JP, Niranjan A, Sheehan JM et al (2005) Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium. J Neurosurg 102(4):678–691PubMedCrossRef
36.
Zurück zum Zitat Wegner RE, Oysul K, Pollock BE et al (2011) A modified radiosurgery-based arteriovenous malformation grading scale and its correlation with outcomes. Int J Radiat Oncol Biol Phys 79(4):1147–1150PubMedCrossRef Wegner RE, Oysul K, Pollock BE et al (2011) A modified radiosurgery-based arteriovenous malformation grading scale and its correlation with outcomes. Int J Radiat Oncol Biol Phys 79(4):1147–1150PubMedCrossRef
37.
Zurück zum Zitat Andratschke N, Zimmermann F, Boehm E et al (2011) Stereotactic radiotherapy of histologically proven inoperable stage I non-small cell lung cancer: patterns of failure. Radiother Oncol 101(2):245–249PubMedCrossRef Andratschke N, Zimmermann F, Boehm E et al (2011) Stereotactic radiotherapy of histologically proven inoperable stage I non-small cell lung cancer: patterns of failure. Radiother Oncol 101(2):245–249PubMedCrossRef
38.
Zurück zum Zitat Stephans K (2012) Stereotactic body radiotherapy for stage I non-small cell lung cancer. Cleve Clin J Med 79(Electronic Suppl1):e26–31CrossRef Stephans K (2012) Stereotactic body radiotherapy for stage I non-small cell lung cancer. Cleve Clin J Med 79(Electronic Suppl1):e26–31CrossRef
39.
Zurück zum Zitat Cox BW, Spratt DE, Lovelock M et al (2012) International spine radiosurgery consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery. Int J Radiat Oncol Biol Phys [Epub ahead of print] Cox BW, Spratt DE, Lovelock M et al (2012) International spine radiosurgery consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery. Int J Radiat Oncol Biol Phys [Epub ahead of print]
40.
Zurück zum Zitat Zamboglou C, Messmer MB, Becker G et al (2012) Stereotactic radiotherapy in the liver hilum. Basis for future studies. Strahlenther Onkol 188(1):35–41PubMedCrossRef Zamboglou C, Messmer MB, Becker G et al (2012) Stereotactic radiotherapy in the liver hilum. Basis for future studies. Strahlenther Onkol 188(1):35–41PubMedCrossRef
41.
Zurück zum Zitat Sautter-Bihl ML, Sedlmayer F, Budach W et al (2010) Intraoperative radiotherapy as accelerated partial breast irradiation for early breast cancer: beware of one-stop shops? Strahlenther Onkol 186(12):651–657PubMedCrossRef Sautter-Bihl ML, Sedlmayer F, Budach W et al (2010) Intraoperative radiotherapy as accelerated partial breast irradiation for early breast cancer: beware of one-stop shops? Strahlenther Onkol 186(12):651–657PubMedCrossRef
42.
Zurück zum Zitat De Ruysscher D, Mark Lodge M, Jones B et al (2012) Charged particles in radiotherapy: a 5-year update of a systematic review. Radiother Oncol 103(1):5–7CrossRef De Ruysscher D, Mark Lodge M, Jones B et al (2012) Charged particles in radiotherapy: a 5-year update of a systematic review. Radiother Oncol 103(1):5–7CrossRef
43.
Zurück zum Zitat Allen AM, Pawlicki T, Dong L et al (2012) An evidence based review of proton beam therapy: the report of ASTRO’s emerging technology committee. Radiother Oncol 103(1):8–11PubMedCrossRef Allen AM, Pawlicki T, Dong L et al (2012) An evidence based review of proton beam therapy: the report of ASTRO’s emerging technology committee. Radiother Oncol 103(1):8–11PubMedCrossRef
44.
Zurück zum Zitat Halperin EC, Perez CA, Brady LW (2008) The discipline of radiation oncology. In: Perez and Brady’s principles and practice of radiation. Oncology, 5. Aufl., S 2–75 Halperin EC, Perez CA, Brady LW (2008) The discipline of radiation oncology. In: Perez and Brady’s principles and practice of radiation. Oncology, 5. Aufl., S 2–75
45.
Zurück zum Zitat Grimm P, Billiet I, Bostwick D et al (2012) Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group. BJU Int 109(Suppl 1):22–29PubMedCrossRef Grimm P, Billiet I, Bostwick D et al (2012) Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group. BJU Int 109(Suppl 1):22–29PubMedCrossRef
Metadaten
Titel
Die technischen und methodischen Entwicklungen der Radioonkologie aus ärztlicher Sicht
verfasst von
Prof. Dr. N. Willich
Publikationsdatum
01.11.2012
Verlag
Springer-Verlag
Erschienen in
Strahlentherapie und Onkologie / Ausgabe Sonderheft 3/2012
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-012-0190-4

Weitere Artikel der Sonderheft 3/2012

Strahlentherapie und Onkologie 3/2012 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.